Tumor microenvironment (TME) consisting of distinct cell types including stromal cells and
immune cells has recently emerged as a pivotal player in tumor development and …

The efficacy of PD-1/PD-L1 blockades is heterogeneous in different molecular subtypes of
gastric cancer (GC). In this study, we analyzed relevant clinical trials to identify the molecular …

Objective This study aimed to identify the mechanism of Yiqi Huayu Decoction (YQHY)
induced ferroptosis in gastric cancer (GC) by using network pharmacology and experimental …

Background. Gastric cancer (GC) is one of the leading causes of cancer‐related mortality
worldwide. There are great geographical differences in the incidence of GC, and somatic …

Purpose Zolbetuximab (IMAB362) is engineered to induce antibody-dependent cell-
mediated cytotoxicity (ADCC) and complement-dependent cytotoxicity. We evaluated ADCC …

Background: In China, traditional Chinese medicines (TCMs), as a complementary therapy
combined with chemotherapy, is widely used in the treatment of gastric cancer (GC). In order …

Brasiliensic acid (Bras) is a chromanone isolated from Calophyllum brasiliense Cambèss.
bark extracts with confirmed potential activity on gastric ulcer and Helicobacter pylori …

Gastric cancer is a malignant tumor with a high incidence and mortality rate worldwide.
Nevertheless, anticancer drugs that can be used for gastric cancer treatment are limited …

Purpose The trend in neoadjuvant therapy for locally advanced gastric cancer (LAGC) is to
use more drugs or therapies in combination. This study aimed to assess the safety and …

Despite advances in biomedical research, gastric cancer remains the leading cause of
morbidity and mortality worldwide due to the limited efficacy of conventional therapies. In …